Theralase Technologies Inc. V.TLT

We are totally blowing Keytruda out of the water

[Eoganacht]

If we get a 450 day 41% durable complete response this will equal Keytruda's 41% CR at any time!

And more than double their 19% 12 month durable CR. 

Keytruda patients could end up being treated up to 34 times! (every 3 weeks for up to 24 months)

And, according to their own website, and depending on what other treatments accompany Keytruda, patients may have to endure:
 
- tiredness or weakness
- nausea
- constipation
- diarrhea
- decreased appetite
- rash
- vomiting
- cough
- trouble breathing
- fever
- hair loss
- inflammation of the nerves that may cause pain
- paralysis in the arms and legs
- low red blood cell count
- low white blood cell count
- decreased platelet count
- high blood pressure
- urinary tract infection
- rash
- low levels of thyroid hormone
- liver problems
- swelling of the lining of the mouth, nose, eyes, throat, intestines, or vagina
- mouth sores
- headache
- weight loss
- stomach-area (abdominal) pain
- joint and muscle pain
- trouble sleeping.

They also advise that this is an incomplete list of possible side effects!

[made2last]

Hi all; Side effects of Tld-1433   Two simple treatments. Feeling well. More time with loved ones. Need more than that? Thanks; made2last  

[Oilminerdeluxe]

That list is what I like to call: the usual Monday at work....  

[N0taP00p]

Two treatments (vs 34), excellent safety profile, better efficacy and duration data, already fast-tracked, single-arm ok'd with a smaller patient dataset (if same or better data), ongoing BCG shortage, no debt, proven GMP capability, future rights to new PDs, potential to treat other cancers, high profile advisor. Seems like this should be at $10 already ..and the reason I hold. Just hoping to

[Alamir1111]

New bcg production plant by merck will be ready by 2026 or sooner.

[O12009]

Merck would be much smarter to turn that plant into a plant to produce tlt-1433 i wonder how much would it take to do that

[Alamir1111]

Cmon merck .80 cents good price

[enriquesuave]

https://twitter.com/pcvblack/status/1693467059328634893/photo/1

[DJDawg]

To add to Enrique's post re Atezolizumab (more famously called Tecentriq) - 6 cm CR 27%, 12m 15.2% - despite IV infusion, every 3wk for a year. - yikes. Ruvidar continues to look great. ----- Phase 2 Trial of Atezolizumab in Bacillus Calmette-Gurin-unresponsive High-risk Non-muscle-invasive Bladder Cancer: SWOG S1605 Peter C Black  1 , Catherine M Tangen  2

[Alamir1111]

Atezolizumad is no longer approved in the US for use in certain patients with bladder  or urinary tract  cancer. Nov 29 2022